HBK Investments »

Catalyst Pharmaceutical Partners shares owned by HBK Investments

Quarter-by-quarter ownership of Catalyst Pharmaceutical Partners (CPRX) shares owned by HBK Investments from 13F filings

Historical chart of HBK Investments investment in Catalyst Pharmaceutical Partners

Tip: Access up to 7 years of quarterly data

All positions including Catalyst Pharmaceutical Partners held by HBK Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Catalyst Pharmaceutical Partners by HBK Investments

Quarter filed Position value Share count Share price at filing
2026-06-30 $89M 2.8M 31.43

More positions owned by HBK Investments

Topbuild
Electronic Arts (EA)
Penumbra (PEN)
Norfolk Southern (NSC)
State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Kenvue (KVUE)
Warner Bros Discovery Com Ser A (WBD)
Bio-techne Corporation (TECH)
Nuvalent Inc-a (NUVL)
Apogee Therapeutics (APGE)
Chart Industries (GTLS)
Teck Resources CL B (TECK)
Janus Henderson Group Ord Shs
Gamestop Corp Note 6/1 (Principal)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)

View all positions for HBK Investments

Top funds holding Catalyst Pharmaceutical Partners

BlackRock
State Street Corporation
American Century Companies
Vanguard Capital Management
Dimensional Fund Advisors
Jpmorgan Chase & Co
Geode Capital Management
HBK Investments
Morgan Stanley
Vanguard Portfolio Management
Jupiter Topco
Qube Research & Technologies
Renaissance Technologies
Henderson Group
Robeco Investment Management

View all funds holding Catalyst Pharmaceutical Partners